Author: TransPerfect Life Sciences The paper-to-digital migration of eCOAs/ePROs has been quite the journey, particularly in light of COVID-19. The rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local regulations. We recently hosted our annual virtual C3 Summit, which included speaker Aaron […]
The post C3 Summit – Shaping the Future of eCOA/ePRO Highlights appeared first on PharmaVOICE.
